Coman, Eugene; Reinus, John F.; Johnson, David A.; Cattau, Edward
June 1990
American Journal of Gastroenterology;Jun1990, Vol. 85 Issue 6, p758
Academic Journal
Deals with the research on the use of cyclosporine in steroid-resistant Crohn's Disease. Background on the participants of the study; Use of a clinical grading scale on the measurement of the activity of the disease; Result of the study.


Related Articles

  • Rapid Closure of Crohn's Disease Fistulas with Continuous Intravenous Cyclosporin A. Hanauer, Stephen B.; Smith, Matthew B. // American Journal of Gastroenterology;May1993, Vol. 88 Issue 5, p646 

    Fistulas complicating Crohn's disease often are refractory to medical management. Immunosuppressive therapy is sometimes effective but requires several months before efficacy can be determined. We treated five patients with Crohn's disease complicated by chronic draining fistulas unresponsive to...

  • NOD2 gene mutations in ulcerative colitis: useless or misunderstood? Freire, Paulo; Cardoso, Ricardo; Figueiredo, Pedro; Donato, Maria; Ferreira, Manuela; Mendes, Sofia; Ferreira, Ana; Vasconcelos, Helena; Portela, Francisco; Sofia, Carlos // International Journal of Colorectal Disease;Jun2014, Vol. 29 Issue 6, p653 

    Purpose: NOD2 mutations have been linked to an increased risk of Crohn's disease and to some of its phenotypes. The association between NOD2 mutations and susceptibility to ulcerative colitis (UC) remains somewhat controversial and potential correlations between these mutations and UC phenotype...

  • Elemental Diet in Steroid--Dependent and Steroid-Refractory Crohn's Disease. O'Brien, C. J.; Giaffer, M. H.; Cann, P. A.; Holdsworth, C. D. // American Journal of Gastroenterology;Nov1991, Vol. 86 Issue 11, p1614 

    Sixteen patients with Crohn's disease who had symptoms uncontrolled by high-dose steroids (n = 11) or symptoms invariably appearing on reduction or withdrawal of immunosuppressive therapy (n = 5) were treated with elemental diet. After 4 wk of dietary treatment, 10 patients were in remission and...

  • Is Mycophenolate Mofetil an Effective Alternative in Azathioprine-Intolerant Patients With Chronic Active Crohn's Disease? Miehsler, Wolfgang; Reinisch, Walter; Moser, Gabriele; Gangl, Alfred; Vogelsang, Harald // American Journal of Gastroenterology;Mar2001, Vol. 96 Issue 3, p782 

    OBJECTIVES: Up to 50% of patients with Crohn's disease (CD) develop steroid dependent or refractory disease requiring immunosuppression. Azathioprine (AZA) is usually used for this purpose but must be withdrawn in up to 10% of patients because of adverse events. Mycophenolate mofetil (MMF) is of...

  • Management of Pyoderma Gangrenosum in a Patient with Crohn's Disease. Alsabbagh, Manal; Kassim, Azad // Bahrain Medical Bulletin;Dec2013, Vol. 35 Issue 4, p1 

    There is no definitive guidelines for the management pyoderma gangrenosum (PG); it is mainly guided by small studies and case reports. We are reporting a case of a middle aged man who presented with pyoderma gangrenosum who was diagnosed with Crohn's disease (CD). His condition was resistant to...

  • Fine-needle aspiration biopsy in renal transplantation. Häyry, Pekka J. // Kidney International;Jul1989, Vol. 36 Issue 1, p130 

    Presents a case of a man of Finnish origin admitted to the University of Helshinki hospital for renal transplantation. Transfusion of leukocyte-poor blood from random donors; Comparison of the efficacy of a regimen consisting of azathioprine and steroids versus cyclosporine; Observation of an...

  • Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Rinaldi, Stefano; Sesto, Antonella; Barsotti, Paola; Faraggiana, Tullio; Sera, Francesco; Rizzoni, Gianfranco // Pediatric Nephrology;Jan2005, Vol. 20 Issue 1, p25 

    Cyclosporin A (CsA) is an effective therapy for children with long-lasting nephrotic syndrome (NS). Long-term treatment can result in chronic CsA nephropathy (CsAN) and there is controversy concerning its incidence and severity. Trough levels are commonly used to monitor the drug concentration....

  • Adalimumab.  // Reactions Weekly;7/9/2011, Issue 1359, p6 

    The article describes two cases of women with Crohn's disease who developed mural aortic thrombosis while undergoing adalimumab therapy.

  • Adalimumab.  // Reactions Weekly;7/9/2011, Issue 1359, p6 

    The article describes the case of a 54-year-old woman with Crohn's disease who developed vitiligo while receiving treatment with adalimumab.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics